María Novella Romanelli

department of neurosciences, psychology, drug research and child's health-section of pharmaceutical and nutraceutical sciences

H指数:31

被引数:3,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy

BRACONI, L.; MATTOLINI, L.; ROMANELLI, M.N.; TEODORI, E.; MANETTI, D. 靶向蛋白酪氨酸磷酸酶1B：用于糖尿病治疗的天然、合成及多靶点抑制剂的最新进展. 生物分子, 2026, 16, 1058. [Google Scholar] [CrossRef] [PubMed]

Biomolecules

IF4.8

2026-08-140

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes

含咪唑环的哌嗪衍生物作为人碳酸酐酶同工酶的选择性调节剂

ChemMedChem

IF3.4

2026-07-030

PRE

Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice

非致幻性伊波加洛苷对化疗诱导的小鼠外周神经病理性疼痛的作用

ACS Chemical Neuroscience

IF3.9

2026-05-010

New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli

新型苄基二氮杂卓烷衍生物能够降低大肠杆菌生物膜形成

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

IF2.2

2026-04-010

OAAI

Modulatory effects of genetic vs. pharmacological HCN4 channel inhibition on stimuli transmission during acute pain

Neuroscience

IF2.8

2026-01-090

OAAI

Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor

新型丙烯酰胺类化合物与α7烟碱乙酰胆碱受体的功能与结构相互作用

Biochemical Pharmacology

IF5.6

2025-10-250

OAAI

Blockade of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels reduces alcohol-induced dopamine release and reward in rats

阻断超极化激活的环核苷酸门控（HCN）通道可减少酒精诱导的多巴胺释放和奖赏效应（在大鼠中）。

Life Sciences

IF5.1

2025-10-240

PRE

Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex

NEUROCHEMISTRY INTERNATIONAL

IF4

2024-09-012

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold

MOLECULES

IF4.6

2024-07-110

OAAI

The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative-and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2024-03-013

OAAI

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023

MOLECULES

IF4.6

2023-12-2112

OAAI

Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-11-014

OAAI

Chemical, Pharmacological, and Structural Characterization of Novel Acrylamide-Derived Modulators of the GABAA Receptor

MOLECULAR PHARMACOLOGY

IF3

2023-09-011

OAAI

DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms

ACS CHEMICAL NEUROSCIENCE

IF3.9

2023-06-306

PRE

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

烟碱型乙酰胆碱受体变构调节剂的发现进展

MOLECULES

IF4.6

2023-01-2817

OAAI

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-10-2113

OAAI

Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury

NEUROTHERAPEUTICS

IF6.9

2022-09-0114

OAAI

The piperazine scaffold for novel drug discovery efforts: the evidence to date

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2022-07-2817

PRE

Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4-Substituted Quinazoline Derivatives

CHEMMEDCHEM

IF3.4

2022-05-127

OAAI

New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators

MOLECULES

IF4.6

2022-01-154

OAAI

María Novella Romanelli

个人简介

教育背景

工作经历

荣誉奖项

研究方向